US launches, cost checks drive Ranbaxy's growth in fourth quarter
26 February 2010
Anju Ghangurde
Please Login to read the full article.
26 February 2010
Anju Ghangurde
aghangurde@yahoo.com
Ranbaxy Laboratories has bounced back into the black during the fourth quarter ended December 31st, 2009, with a net profit of $54 million, as against a loss of $142 million in the same quarter of the previous year.
Sales rose by 25% to $482 million, backed by the launch of two first-to-file...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
